Sign in
CompletedNo phase

Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS)

Key facts

Who runs it
Sahlgrenska University Hospital
Where
Sweden2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
50 people enrolled
Started
17 Oct 2022
Ended
30 May 2025
Type of study
Interventional
Treatments tested
  • Gut-directed hypnotherapy
Record updated
12 January 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • IBS diagnosis

Who cannot take part

  • Organic GI disease

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Adult IBS patients with symptoms refractory to standard medical treatment will receive online nurse-administered, gut-directed hypnotherapy in groups. The primary outcome measure was change in gastro-intestinal symptom severity. Secondary outcomes are GI-specific anxiety, general anxiety and depression, quality of life, and extracolonic symptom severity. Usability of the digital platform as well as patient treatment satisfaction will also be assessed.

The group in the trial

  • Nurse-delivered, gut-directed hypnotherapyOther group

    Treatment: Gut-directed hypnotherapy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
12 January 2026